<DOC>
	<DOC>NCT00301665</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of botulinum toxin type A (Dysport®) injections into pericranial muscles compared to placebo to prevent migraine attacks.</brief_summary>
	<brief_title>Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients having migraine without aura or with typical aura as defined by International Headache Society criteria Migraine attacks have been persisting for more than 1 year 2 to 6 migraine attacks per month of at least moderate severity over the 3 months preceding the preinclusion visit 2 to 6 migraine attacks of at least moderate severity during the screening period Nonmigraine headaches such as tensiontype headaches Migraine with prolonged aura, familial hemiplegic migraine, basilar migraine, migraine aura without headache, migraine with acute onset aura, ophthalmoplegic migraine, retinal migraine, complications of migraine Onset of migraine is after age of 50 Overuse of acute migraine medications (individuals who take medications for acute migraine more than 10 days per month) or have a history of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>